OOIR: Observatory of International Research

Papers

(The H4-Index of Multiple Sclerosis and Related Disorders is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
The Use of Ocrelizumab in Pediatric Multiple Sclerosis Patients in the United Arab Emirates: A Retrospective Study	94
Involvement Peripheral Nerve System in Multiple Sclerosis	67
Leber Hereditary Optic Neuropathy Presenting as Bilateral Visual Loss and White Matter Disease	57
Sexual Dysfunctions and Self-Esteem in Multiple Sclerosis: A Tunisian Study	54
Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets	52
The Relationship Between Smoking and Multiple Sclerosis Severity in Saudi Arabia	51
Missed MS or MIMS not prodromal MS: Expanding the diagnostic MS spectrum	49
Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in Italy	44
Italian translation and psychometric validation of the ABILHAND-26 and its correlation with upper limb objective and subjective measures in multiple sclerosis subjects	44
Peripheral nerve vulnerability as risk factor for multiple sclerosis: Possible insights from Neurofibromatosis type 2 (NF2)	43
Epidemiology of familial multiple sclerosis and its comparison to sporadic form in Markazi Province, Iran	42
Effects of constraint induced movement therapy in patients with multiple sclerosis: A systematic review	41
Preliminary race-ethnicity-based analyses of fall risk among people with multiple sclerosis	40
Functional electrical stimulation combined with voluntary cycling accentuates VO2 response in people with severe multiple sclerosis: A pilot study	39
Test-retest reliability of the Swedish version of the Modified Fatigue Impact Scale in people with mild to moderate multiple sclerosis	39
57. Cognitive Decline and Motor Handicap in Multiple Sclerosis Patients	39
Psychometric measurement properties and reference values of the six-spot step test, the six-minute walk test, the 25-foot walk test, and the 12-item multiple sclerosis walking scale in people with mul	39
125. Investigating Psychoses in Pediatric-Onset Multiple Sclerosis: A Systematic Review of Case Reports	37
143. Navigating the Maze of Multiple Sclerosis Disease Modifying Therapies: Insights from Iran's National MS Registry	37
Multiple sclerosis disease-modifying therapy use in the department of veteran affairs and Medicare: A comparative analysis	37
157. Remibrutinib Exposure in Cerebrospinal Fluid: Insights from a Study in Healthy Subjects	37
Influence of Cigarette, and Waterpipe Smoking, Alcohol, and Drug Consumption on the Occurrence of Late-Onset Multiple Sclerosis	34
The relationship between cognitive impairment, cognitive fatigue, and visual evoked potential latency in people with multiple sclerosis	34
The Management of Lower Urinary Tract Symptoms in Multiple Sclerosis: an Umbrella Review	34
Sexual problems in MS: Sex differences and their impact on quality of life	33

Characteristics of Patients with Newly Diagnosed Multiple Sclerosis: A Five-Year Study at Benghazi Medical Center, Benghazi, Libya	33
EDSS and Infratentorial White Matter Lesion Volume are Considered Predictors of Fatigue Severity in RRMS	33
Characterizing causal relationships of visceral fat and body shape on multiple sclerosis risk	33
Real-World Evidence with Five-Year Data (2017-2022) on the Use of Cladribine Tablets in Patients with Multiple Sclerosis in England: an Updated Analysis from the CLARENCE Study	33
Clinical and imaging features of patients with late-onset myelin oligodendrocyte glycoprotein antibody-associated disease	32
Risk factors for development of lymphopenia in dimethyl fumarate-treated patients with multiple sclerosis	32
Incidence of multiple sclerosis relapses and pseudo-relapses following COVID-19 vaccination	32
Index of cardiac-electrophysiological balance in relapsing–remitting multiple sclerosis patients treated with fingolimod	32
Autoimmune encephalitis: A retrospective monocentric experience	32
How Much Is Enough? Determining Minimum Valid Tracking Periods for Reliable Physical Activity Monitoring	32
Symptoms of PTSD and depression in newly diagnosed people with multiple sclerosis during the outbreak Oct.7th war on Gaza: A case-control study from Jordan	32